Company Overview and News

 
Greenpower Energy reveals high-grade lithium from Morabisi Project

2018-01-01 proactiveinvestors.com.au
Greenpower Energy Limited’s (ASX:GPP) latest results from its Morabisi Lithium/REE project located in Guyana, South America have featured encouraging lithium values.

 
Greenpower Energy calls for halt pending update on lithium-tantalum acquisition

2017-11-06 proactiveinvestors.com.au
Greenpower Energy Ltd (ASX:GPP) has been undertaking a transition into the lithium-tantalum sector through the acquisition of a project in Guyana.

 
Greenpower Energy tops the ASX Most Active on lithium results

2017-10-25 proactiveinvestors.com.au
Greenpower Energy Ltd (ASX:GPP) is the most active stock on the ASX at midday, with 106 million shares changing hands for a gain of 79% to $0.025.

 
Greenpower Energy to reveal results

2017-06-20 proactiveinvestors.com.au
Greenpower Energy (ASX:GPP) has been granted a trading halt by the ASX, pending OHD trial results.

 
Greenpower Energy to reveal lithium results

2017-03-28 proactiveinvestors.com.au
Greenpower Energy (ASX:GPP) has been granted a trading halt by the ASX, pending assay lab results for the company's Morabisi Lithium project.

 
Greenpower Energy to reveal update on fertiliser project

2017-02-13 proactiveinvestors.com.au
Greenpower Energy (ASX:GPP) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.

 
Greenpower Energy in an ASX trading halt

2017-01-22 proactiveinvestors.com.au
The company is pending details on the results of the Company General Meeting to be held on Monday, 23rd January.

 
Greenpower Energy to update on lithium

2016-12-02 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Tuesday 6th December 2016, or earlier if an announcement is made to the market.

 
Greenpower Energy Ltd to outline strategic placement

2016-11-16 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Monday 21st November 2016, or earlier if an announcement is made to the market.

 
Greenpower Energy is the ASX Volume Leader at the close

2016-11-04 proactiveinvestors.com.au

 
Greenpower Energy is ASX Volume Leaders at the close

2016-11-03 proactiveinvestors.com.au

 
Greenpower Energy Ltd to reveal farm-in agreement

2016-09-18 proactiveinvestors.com.au
Greenpower Energy Ltd (ASX:GPP) has been granted a trading halt by the ASX, pending details of a farm-in agreement. The halt will remain in place until the opening of trade on Tuesday 20th September 2016, or earlier if an announcement is made to the market.

 
Greenpower Energy Ltd to respond to ASX price query

2016-08-12 proactiveinvestors.com.au
Greenpower Energy Ltd (ASX:GPP) has been granted a trading halt by the ASX this afternoon, pending a response to a price query. The halt will remain in place until the opening of trade on Tuesday 16th August 2016, or earlier if an announcement is made to the market.

 
Greenpower Energy Ltd to lift cash position

2016-07-27 proactiveinvestors.com.au
Greenpower Energy Ltd (ASX:GPP) is preparing to reveal details of a capital raising, with the ASX granting the company a trading halt. The company is focused on the development and commercialisation of its unique coal conversion process. The halt will remain in place until the opening of trade on Friday 29th July 2016, or earlier if an announcement is made to the market.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...